Loncar China BioPharma ETF (CHNA) 📈: графики для анализа доходности фонда Loncar China BioPharma ETF

Kategorie	Aktie, %	Menge
Healthcare	34.33	15

Land	Menge	Unternehmen
China	10	AIM Vaccine Co., Ltd. (aktie - 3.97%) Sinopharm Group Co. Ltd. (aktie - 2.54%) Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (aktie - 2.32%) BeiGene, Ltd. (aktie - 2.27%) WuXi AppTec Co., Ltd. (aktie - 2.25%) Hansoh Pharmaceutical Group Company Limited (aktie - 2.19%) CSPC Pharmaceutical Group Limited (aktie - 2%) Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (aktie - 1.99%) Shanghai Pharmaceuticals Holding Co., Ltd (aktie - 1.99%) Livzon Pharmaceutical Group Inc. (aktie - 1.93%)
United States	1	Legend Biotech Corporation (aktie - 2.98%)
Hong Kong	4	Sino Biopharmaceutical Limited (aktie - 2.15%) CK Life Sciences Int'l., (Holdings) Inc. (aktie - 1.92%) China Resources Pharmaceutical Group Limited (aktie - 1.92%) China Medical System Holdings Limited (aktie - 1.91%)

Investing Port